NCT06314698 2024-03-18Narlumosbart Compared With Denosumab in Patients With Multiple Myeloma Bone DiseaseRenJi HospitalPhase 3 Not yet recruiting478 enrolled
NCT01582295 2017-05-25XL184 For Relapsed/Refractory Multiple Myeloma (MM) With Bone DiseaseMassachusetts General HospitalPhase 1 Completed4 enrolled